Strategy | Financing | Macro & Markets Private Placement / Financing Transactions OpenEvidence: The company raised $210 million of Series B venture funding in a deal led by GV and Kleiner Perkins on July 15, 2025, putting the company’s pre-money valuation at...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Nuclidium: The company raised EUR 84 million of Series B venture funding in a deal led by Angelini Ventures, Kurma Partners, Wellington Partners and NEVA SGR on July 10, 2025....
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Kardium: The company raised $250 million of venture funding in a deal led by MMCAP International, Eckuity, and Eventide Asset Management on July 2, 2025. Janus Henderson Investors,...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abridge: The company raised $354 million of Series E venture funding in a deal led by Andreessen Horowitz on June 24, 2025. Khosla Ventures and Other undisclosed investors also...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Commure: The company raised $200 million of venture funding from General Catalyst on June 19, 2025. The company is a developer of a cloud-based interoperable platform designed to...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Antares Therapeutics: The company raised $177 million of Series A venture funding in a deal led by Cormorant Asset Management, Omega Funds, Atlas Venture, BVF Partners and Lightspeed...
